Skip to main content

Table 3 Performance of ESLA-7 in multivariate setting when adjusted for age, stage and stratified for gender

From: A robust prognostic gene expression signature for early stage lung adenocarcinoma

Cohort HR CI p N events
Lee et al. 2008 [4] 2.9 1.2–7.1 * 51 24
Zhu et al. 2010 [5] 4.9 1.3–18.1 * 32 14
Shedden et al. 2008 [6] 2.0 1.2–3.5 * 207 64
Rousseaux et al. 2013 [7] 2.6 1.2–5.8 * 84 31
Okayama et al. 2012 [8] 3.1 1.2–7.9 * 204 27
Botling et al. 2013 [9] 1.1 0.3–3.9   35 14
Der et al. 2014 [10] 3.2 1.6–6.2 *** 127 44
  1. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001